Exhibiting at VIV Asia 2025

SP Veterinaria, S.A. is a Spanish veterinary pharmaceutical company headquartered in Riudoms, Tarragona, Spain. For over four decades, the company has been a recognized leader in the development, manufacturing, and global distribution of high-quality veterinary medicines and animal health products. With a presence in more than 60 countries, SP Veterinaria is committed to improving animal welfare and performance across livestock, poultry, and companion animal sectors.

Core Business

SP Veterinaria operates as a fully integrated pharmaceutical company focusing on:

• Development and manufacture of veterinary drugs
• Production of feed supplements, disinfectants, and antiparasitic treatments
• Export of licensed and certified animal health solutions to global markets

The company supports the health and productivity of livestock through innovative treatments that meet regulatory and performance standards in animal husbandry.

Product and Service Offerings

SP Veterinaria’s comprehensive product portfolio includes:

• Antibacterials

  • AMOXICILLIN GLOBAL VET HEALTH 500 mg/g
  • CEFAVEX 50 mg/ml
  • Colimicina Polvo Hidrosoluble
  • COLMYC® -E / QUINOFLOX

• Antiparasitics

  • Anthelmin Oral
  • Coccivex / Coccibal®

• Anti-inflammatories and Antipyretics

  • PIRESOL®
  • PARACETAMOL S.P.

• Symptomatics and Supportive Therapies

  • Neumovex

• Nutritional and Metabolic Supplements

  • AVI-B Liquid
  • AVIFOS
  • GLEPTOVEX
  • GLUCOGEN

• Revitalizing and Performance Enhancers

  • ESVEX

• Insecticides and External Parasite Control

  • PIREVEEX PLUS
  • IVERTOTAL

• Disinfectants

  • Yodo S. P.
  • Yodorvex

All formulations are backed by scientific research and are designed for high efficacy, safety, and ease of administration under intensive livestock production systems.

Specialization and Unique Selling Proposition

SP Veterinaria distinguishes itself through:

• A dedicated R&D team with expertise in pharmacology, microbiology, and veterinary science
• EU-GMP certified production facilities, ensuring international compliance
• Strong presence in injectables, soluble powders, and oral liquid formulations
• Capability for regulatory dossier development, allowing fast market access
• Solutions designed specifically for intensive production systems, with a focus on minimizing antimicrobial resistance

Financials and Business Strength

Though privately held, SP Veterinaria is considered a medium-sized enterprise with robust international performance:

• Estimated annual revenue: €20–30 million
• Exports constitute over 70% of total sales
• Growth rate averaging 8–10% CAGR over the past 5 years
• Operates in 60+ countries, with strategic partners across Latin America, Asia, and the Middle East

International Reach and Shipments

SP Veterinaria is a key exporter of veterinary pharmaceuticals, with an active presence in:

• Europe: Portugal, Italy, Romania, Poland
• Latin America: Mexico, Colombia, Peru
• Asia: Vietnam, Philippines, India
• Africa and MENA: Egypt, Morocco, Nigeria

The company collaborates with local partners for distribution, product registration, and after-sales support. According to export data from trade intelligence platforms, SP Veterinaria has conducted over 500 international shipments annually in recent years.

Target Market

The company targets:

• Veterinarians and livestock practitioners
• Animal health distributors and pharmaceutical wholesalers
• Poultry and swine integrators
• Pharmaceutical tenders in public and private animal health programs
• Feed and animal production companies

SP Veterinaria focuses heavily on the poultry and swine segments, where disease prevention and performance optimization are critical to profitability.

Capabilities

• GMP-certified production plants for veterinary drugs and supplements
• Dedicated analytical and microbiology labs
• Dossier preparation and regulatory affairs team
• Flexible production lines for small and large batch manufacturing
• Multilingual technical support and product training for clients

Certifications and Compliance

• EU-GMP Certification – Pharmaceutical Good Manufacturing Practices
• ISO 9001:2015 – Quality Management Systems
• Compliant with Spanish and EU Medicines Agency regulations
• Products registered in over 50 international regulatory bodies
• Adheres to pharmacovigilance and antibiotic stewardship guidelines

Customer Testimonials

“SP Veterinaria's Amoxicillin and Colimicina are among the most consistent and reliable treatments we've used for enteric diseases. Their team is responsive and technically strong.”
— Livestock Veterinarian, Central America

“Their Coccivex anticoccidial product has helped us reduce coccidiosis outbreaks by 40%. We're also impressed with their nutritional supplements.”
— Technical Manager, Poultry Integrator, South Asia

Major Achievements

• Developed over 80 registered products across 10 therapeutic categories
• Achieved EU-GMP certification for both oral and injectable lines
• Expanded into Latin America and Asia with dedicated field teams and regional support
• Featured as a top Spanish veterinary exporter by veterinary industry bodies
• Active participation in VIV, EuroTier, and regional veterinary congresses

With a legacy of pharmaceutical precision, scientific innovation, and global adaptability, SP Veterinaria, S.A. remains a trusted name in the field of animal health, delivering targeted solutions to meet the evolving needs of veterinarians and livestock producers worldwide.